Kanabo Group PLC
LSE:KNB
Kanabo Group PLC
LSE:KNB
Price:
0.225
GBX
Market Closed
Market Cap:
£1.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kanabo Group PLC
LSE:KNB
|
UK |
|
Sandmartin International Holdings Ltd
HKEX:482
|
HK |
|
China Gold International Resources Corp Ltd
TSX:CGG
|
CA |
|
Mitre Realty Empreendimentos e Participacoes SA
BOVESPA:MTRE3
|
BR |
|
Kore Potash PLC
LSE:KP2
|
UK |
|
Viking Therapeutics Inc
NASDAQ:VKTX
|
US |
|
MDJM Ltd
NASDAQ:UOKA
|
UK |
|
B
|
Bekasi Fajar Industrial Estate Tbk PT
IDX:BEST
|
ID |
|
H
|
Herbal Dispatch Inc
CNSX:HERB
|
CA |
|
M
|
Medimaging Integrated Solution Inc
TWSE:6796
|
TW |
|
C
|
China Star Food Group Ltd
SGX:42W
|
SG |
|
Alexander & Baldwin Inc (Hawaii)
NYSE:ALEX
|
US |
|
P
|
P10 Inc
NYSE:PX
|
US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
US |
|
Formosa Plastics Corp
TWSE:1301
|
TW |
Income Statement
Earnings Waterfall
Kanabo Group PLC
Kanabo Group PLC
Income Statement
Kanabo Group PLC
Kanabo Group PLC
Currency: GBP
| Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+387%
|
0
+307%
|
1
+103%
|
1
+35%
|
1
+10%
|
1
+27%
|
|
| Gross Profit | |||||||||||
| Cost of Revenue |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
+1 314%
|
0
+101%
|
0
-6%
|
0
-29%
|
0
-33%
|
|
| Operating Income | |||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(1)
|
(3)
|
(5)
|
(6)
|
(4)
|
(4)
|
(4)
|
|
| Selling, General & Administrative |
0
|
0
|
0
|
(1)
|
(3)
|
(4)
|
(5)
|
(3)
|
(2)
|
(2)
|
|
| Research & Development |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(1)
|
(1)
|
(1)
|
|
| Other Operating Expenses |
(0)
|
(0)
|
(0)
|
0
|
0
|
(1)
|
0
|
1
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
+13%
|
(0)
+51%
|
(1)
-695%
|
(3)
-126%
|
(5)
-90%
|
(5)
-1%
|
(3)
+38%
|
(4)
-12%
|
(4)
-1%
|
|
| Pre-Tax Income | |||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(1)
|
(2)
|
(1)
|
(1)
|
(2)
|
(5)
|
(4)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
+15%
|
(0)
+57%
|
(2)
-1 737%
|
(5)
-89%
|
(6)
-31%
|
(7)
-16%
|
(5)
+32%
|
(8)
-72%
|
(8)
-2%
|
|
| Net Income | |||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(2)
|
(5)
|
(6)
|
(7)
|
(5)
|
(8)
|
(8)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
+15%
|
(0)
+57%
|
(2)
-1 737%
|
(5)
-89%
|
(6)
-31%
|
(7)
-16%
|
(5)
+32%
|
(8)
-72%
|
(8)
-2%
|
|
| EPS (Diluted) |
-0.01
N/A
|
-0.01
N/A
|
0
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
